Company Name:Incyte Corporation
CEO: Herve Hoppenot

Sector: Healthcare
Industry:Biotechnology

Exchange: Nasdaq Global Select

Country: USA

Description: Incyte Corp is a biopharmaceutical company. It discovers, develops and commercializes proprietary therapeutics. Its product JAKAFI, a JAK1 and JAK2 inhibitor is used for treatment of patients with intermediate or high risk myelofibrosis.


Key numbers

Market Capitalization:18674919900
Shares Outstanding: 215397000
Float: 213612651.252
Next Earning Date:2020-02-14
TTm EPS: 1.8868
TTm Dividend Rate:
200 days moving average:81.17
50 days moving average: 79.02
One day percent Change: 2.54



2018-06-30, 2018-09-30, 2018-12-31, 2019-03-31,
2018-06-30, 2018-09-30, 2018-12-31, 2019-03-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,